The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / September / COVID-19 May Reactivate Dormant Viruses
Biochemistry and molecular biology Infectious Disease Screening and monitoring Insights

COVID-19 May Reactivate Dormant Viruses

Nearly half of hospitalized patients had detectable reactivation of at least one chronic virus

09/07/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Topic Commentary

Share

5 Key Takeaways
  • 1

    Nearly half of hospitalized COVID-19 patients had detectable reactivation of at least one chronic virus during acute illness.

  • 2

    The study included 1,154 unvaccinated patients admitted to 20 US hospitals between May 2020 and March 2021.

  • 3

    Chronic viral transcripts were found in 550 of 1,148 evaluable patients within the first 40 days of admission.

  • 4

    Herpesvirus and Anelloviridae transcripts were linked to greater COVID-19 severity and one-year mortality in critically ill patients.

  • 5

    The study's limitations include reliance on RNA sequencing and a cohort limited to unvaccinated patients with early SARS-CoV-2 variants.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.